AI in Medical Imaging Market (By Image Acquisition Technology: X-Ray, Computed Tomography, Magnetic Resonance Imaging, Ultrasound Imaging, Molecular Imaging; By End Use: Hospitals and Clinics, Research Laboratories and Diagnostic Centers, Others ; By Application: Digital Pathology, Oncology, Cardiovascular, Neurology, Lung, Breast, Liver, Oral Diagnostics, Other) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: AI in Medical Imaging Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. AI in Medical Imaging Market, by AI Technology, 2023-2032
8.1.1. Deep Learning
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Natural Language Processing (NLP)
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2020-2032)
9.1. AI in Medical Imaging Market, by Solution, 2023-2032
9.1.1. Software Tools/ Platform
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Services
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Integration
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Deployment
9.1.4.1. Market Revenue and Forecast (2020-2032)
10.1. AI in Medical Imaging Market, by Modality, 2023-2032
10.1.1. CT Scan
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. MRI
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. X-rays
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Ultrasound Imaging
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Nuclear Imaging
10.1.5.1. Market Revenue and Forecast (2020-2032)
11.1. AI in Medical Imaging Market, by Application, 2023-2032
11.1.1. Digital Pathology
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Oncology
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Cardiovascular
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Neurology
11.1.4.1. Market Revenue and Forecast (2020-2032)
11.1.5. Lung (Respiratory System)
11.1.5.1. Market Revenue and Forecast (2020-2032)
11.1.6. Breast (Mammography)
11.1.6.1. Market Revenue and Forecast (2020-2032)
11.1.7. Liver (GI)
11.1.7.1. Market Revenue and Forecast (2020-2032)
11.1.8. Oral Diagnostics
11.1.8.1. Market Revenue and Forecast (2020-2032)
11.1.9. Other
11.1.9.1. Market Revenue and Forecast (2020-2032)
12.1. AI in Medical Imaging Market, by End Use, 2023-2032
12.1.1. Hospital and Healthcare Providers
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Patients
12.1.2.1. Market Revenue and Forecast (2020-2032)
12.1.3. Pharmaceuticals and Biotechnology Companies
12.1.3.1. Market Revenue and Forecast (2020-2032)
12.1.4. Healthcare Payers
12.1.4.1. Market Revenue and Forecast (2020-2032)
12.1.5. Others
12.1.5.1. Market Revenue and Forecast (2020-2032)
13.1. North America
13.1.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.1.2. Market Revenue and Forecast, by Solution (2020-2032)
13.1.3. Market Revenue and Forecast, by Modality (2020-2032)
13.1.4. Market Revenue and Forecast, by Application (2020-2032)
13.1.5. Market Revenue and Forecast, by End Use (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.1.6.2. Market Revenue and Forecast, by Solution (2020-2032)
13.1.6.3. Market Revenue and Forecast, by Modality (2020-2032)
13.1.6.4. Market Revenue and Forecast, by Application (2020-2032)
13.1.6.5. Market Revenue and Forecast, by End Use (2020-2032)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.1.7.2. Market Revenue and Forecast, by Solution (2020-2032)
13.1.7.3. Market Revenue and Forecast, by Modality (2020-2032)
13.1.7.4. Market Revenue and Forecast, by Application (2020-2032)
13.1.7.5. Market Revenue and Forecast, by End Use (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.2.2. Market Revenue and Forecast, by Solution (2020-2032)
13.2.3. Market Revenue and Forecast, by Modality (2020-2032)
13.2.4. Market Revenue and Forecast, by Application (2020-2032)
13.2.5. Market Revenue and Forecast, by End Use (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.2.6.2. Market Revenue and Forecast, by Solution (2020-2032)
13.2.6.3. Market Revenue and Forecast, by Modality (2020-2032)
13.2.7. Market Revenue and Forecast, by Application (2020-2032)
13.2.8. Market Revenue and Forecast, by End Use (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.2.9.2. Market Revenue and Forecast, by Solution (2020-2032)
13.2.9.3. Market Revenue and Forecast, by Modality (2020-2032)
13.2.10. Market Revenue and Forecast, by Application (2020-2032)
13.2.11. Market Revenue and Forecast, by End Use (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.2.12.2. Market Revenue and Forecast, by Solution (2020-2032)
13.2.12.3. Market Revenue and Forecast, by Modality (2020-2032)
13.2.12.4. Market Revenue and Forecast, by Application (2020-2032)
13.2.13. Market Revenue and Forecast, by End Use (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.2.14.2. Market Revenue and Forecast, by Solution (2020-2032)
13.2.14.3. Market Revenue and Forecast, by Modality (2020-2032)
13.2.14.4. Market Revenue and Forecast, by Application (2020-2032)
13.2.15. Market Revenue and Forecast, by End Use (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.3.2. Market Revenue and Forecast, by Solution (2020-2032)
13.3.3. Market Revenue and Forecast, by Modality (2020-2032)
13.3.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.5. Market Revenue and Forecast, by End Use (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.3.6.2. Market Revenue and Forecast, by Solution (2020-2032)
13.3.6.3. Market Revenue and Forecast, by Modality (2020-2032)
13.3.6.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.7. Market Revenue and Forecast, by End Use (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.3.8.2. Market Revenue and Forecast, by Solution (2020-2032)
13.3.8.3. Market Revenue and Forecast, by Modality (2020-2032)
13.3.8.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.9. Market Revenue and Forecast, by End Use (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.3.10.2. Market Revenue and Forecast, by Solution (2020-2032)
13.3.10.3. Market Revenue and Forecast, by Modality (2020-2032)
13.3.10.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.10.5. Market Revenue and Forecast, by End Use (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.3.11.2. Market Revenue and Forecast, by Solution (2020-2032)
13.3.11.3. Market Revenue and Forecast, by Modality (2020-2032)
13.3.11.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.11.5. Market Revenue and Forecast, by End Use (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.4.2. Market Revenue and Forecast, by Solution (2020-2032)
13.4.3. Market Revenue and Forecast, by Modality (2020-2032)
13.4.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.5. Market Revenue and Forecast, by End Use (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.4.6.2. Market Revenue and Forecast, by Solution (2020-2032)
13.4.6.3. Market Revenue and Forecast, by Modality (2020-2032)
13.4.6.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.7. Market Revenue and Forecast, by End Use (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.4.8.2. Market Revenue and Forecast, by Solution (2020-2032)
13.4.8.3. Market Revenue and Forecast, by Modality (2020-2032)
13.4.8.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.9. Market Revenue and Forecast, by End Use (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.4.10.2. Market Revenue and Forecast, by Solution (2020-2032)
13.4.10.3. Market Revenue and Forecast, by Modality (2020-2032)
13.4.10.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.10.5. Market Revenue and Forecast, by End Use (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.4.11.2. Market Revenue and Forecast, by Solution (2020-2032)
13.4.11.3. Market Revenue and Forecast, by Modality (2020-2032)
13.4.11.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.11.5. Market Revenue and Forecast, by End Use (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.5.2. Market Revenue and Forecast, by Solution (2020-2032)
13.5.3. Market Revenue and Forecast, by Modality (2020-2032)
13.5.4. Market Revenue and Forecast, by Application (2020-2032)
13.5.5. Market Revenue and Forecast, by End Use (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.5.6.2. Market Revenue and Forecast, by Solution (2020-2032)
13.5.6.3. Market Revenue and Forecast, by Modality (2020-2032)
13.5.6.4. Market Revenue and Forecast, by Application (2020-2032)
13.5.7. Market Revenue and Forecast, by End Use (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by AI Technology (2020-2032)
13.5.8.2. Market Revenue and Forecast, by Solution (2020-2032)
13.5.8.3. Market Revenue and Forecast, by Modality (2020-2032)
13.5.8.4. Market Revenue and Forecast, by Application (2020-2032)
13.5.8.5. Market Revenue and Forecast, by End Use (2020-2032)
14.1. Agfa-Gevaert Group/Agfa HealthCare
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Arterys
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. AI
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. AZmed
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Butterfly Network
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Caption Health
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. CellmatiQ
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. dentalXrai
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Digital Diagnostics
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. EchoNous
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample